メトトレキサートの市場規模：適応症別、様式別、合成タイプ別-世界予測、2023～2032年

世界のメトトレキサート市場は、活況を呈する製薬部門に後押しされ、2032年までCAGR5％以上を記録する展望です。

医療の優先事項が進化するにつれて、効果的な治療オプションへの需要が高まり、製品の治療用途が広がっていることが強調されています。

慢性疾患の増加も主な成長要因のひとつです。2023年のWHOの報告によると、非感染性疾患（NCDs）は毎年4,100万人の命を奪っており、これは世界の死亡者数の74%を占める。特に、1,700万人が70歳以下でNCDsに罹患し、その86%が中低所得国で発生しています。定評のある疾患修飾性抗リウマチ薬（DMARD）であるメトトレキサートは、関節リウマチや乾癬などの自己免疫疾患の治療に有効であるため、採用が増加しています。さらに、がん治療、特に白血病と乳がんにおけるその役割は、市場の成長に大きく貢献しています。

がん分野は、白血病、乳がん、ある種のリンパ腫の化学療法プロトコールにおけるメトトレキサートの有用性により、2023年から2032年にかけて大幅な成長が見込まれます。多様ながん治療におけるメトトレキサートの可能性の継続的な探求は、がん領域における基礎治療薬としてのメトトレキサートの重要性を強調しています。

受託製造分野は、予測期間中に力強い成長が見込まれます。製薬企業は、生産プロセスの合理化、効率性の向上、規制基準の遵守を確実にするために、製造受託機関（CMO）を活用するようになっています。CMOとの提携により、メトトレキサートのシームレスな生産と流通が促進され、技術革新が促進され、世界的に患者への幅広いアクセスが確保されます。

アジア太平洋のメトトレキサート市場は、急増する人口と進化する医療インフラに牽引され、2032年まで急速な成長を記録すると予想されます。慢性疾患の有病率が増加しており、効果的な治療オプションに対する需要が高まっています。中国やインドのような製薬部門が拡大している国々は、メトトレキサートの生産と消費において重要な役割を果たしており、それによって地域の市場力学が形成されています。

目次

第1章 調査手法と調査範囲

第2章 エグゼクティブサマリー

第3章 メトトレキサート産業洞察

• COVID-19影響分析
• エコシステム分析
• 技術情勢
• 規制状況
• 業界への影響要因
  • 促進要因
    • 慢性疾患の増加
    • 規制当局による医薬品承認数の増加
    • メトトレキサート製剤を用いた継続的な研究開発
    • 技術進歩と個別化医療への需要の高まり
  • 業界の潜在的リスク＆課題
    • 副作用と安全性への懸念
    • 限られた償還と保険適用政策
• 成長可能性分析
• ポーター分析
• PESTEL分析

第4章 競合情勢

• イントロダクション
  • Novartis AG（Sandoz）
  • Merck & Co., Inc
  • Sun Pharmaceutical Industries Ltd
• 競合のポジショニングマトリックス
• 市場シェア／順位分析
  • 世界
  • 北米
  • 欧州
  • アジア太平洋
• 生産能力
• 最終消費者上位20社のリストと連絡先/メールアドレス

第5章 メトトレキサート市場推定・予測：適応症別

• 主要動向：適応症別
• 乾癬
• 関節リウマチ
• がん
• その他

第6章 メトトレキサート市場推定・予測、モード別

• 主要動向：モード別
• 自社製造
• 受託製造

第7章 メトトレキサート市場推定・予測、合成タイプ別

• 主要動向：合成タイプ別
• 化学ベースのAPI
• 高活性API（HPAPI）

第8章 メトトレキサートの市場推定・予測：地域別

• 主要動向：地域別
• 北米
  • 米国
  • カナダ
• 欧州
  • ドイツ
  • 英国
  • フランス
  • イタリア
  • スペイン
  • ロシア
• アジア太平洋
  • 中国
  • 日本
  • インド
  • オーストラリア
  • 韓国
  • マレーシア
• ラテンアメリカ
  • ブラジル
  • メキシコ
• 中東・アフリカ
  • サウジアラビア
  • 南アフリカ
  • アラブ首長国連邦

第9章 企業プロファイル

• Teva Pharmaceutical Industries Ltd
• Sun Pharmaceutical Industries Ltd
• Aurobindo Pharma Ltd
• Lonza Group AG
• Merck & Co., Inc
• Fermion（Orion Corporation）
• Avra Laboratories Pvt Ltd
• Rochem International Inc
• LGM Pharm
• Sandoz AG（Novartis AG）

Data Tables

• TABLE 1. Global methotrexate market size, 2018 - 2024 (USD Million)
• TABLE 2. Global methotrexate market size, 2025 - 2032 (USD Million)
• TABLE 3. Global methotrexate market size, by region, 2018 - 2024 (USD Million)
• TABLE 4. Global methotrexate market size, by region, 2025 - 2032 (USD Million)
• TABLE 5. Global methotrexate market size, by indication, 2018 - 2024 (USD Million)
• TABLE 6. Global methotrexate market size, by indication, 2025 - 2032 (USD Million)
• TABLE 7. Global methotrexate market size, by mode, 2018 - 2024 (USD Million)
• TABLE 8. Global methotrexate market size, by mode, 2025 - 2032 (USD Million)
• TABLE 9. Global methotrexate market size, by synthesis type, 2018 - 2024 (USD Million)
• TABLE 10. Global methotrexate market size, by synthesis type, 2025 - 2032 (USD Million)
• TABLE 11. Comprehensive study of API supply chain of the U.S. and Europe
• TABLE 12. Basic differences in API registration in the U.S. AND EU
• TABLE 13. Innovation & sustainability in methotrexate
• TABLE 14. Methotrexate selling price per kg, by region, 2022
• TABLE 15. Competitive positioning matrix: Classification criteria
• TABLE 16. Production capacity, 2022
• TABLE 17. List of top 20 end consumers with contact details/email id
• TABLE 18. Psoriasis market size, 2018 - 2024 (USD Million)
• TABLE 19. Psoriasis market size, 2025 - 2032 (USD Million)
• TABLE 20. Rheumatoid arthritis market size, 2018 - 2024 (USD Million)
• TABLE 21. Rheumatoid arthritis market size, 2025 - 2032 (USD Million)
• TABLE 22. Cancer market size, 2018 - 2024 (USD Million)
• TABLE 23. Cancer market size, 2025 - 2032 (USD Million)
• TABLE 24. Other indications market size, 2018 - 2024 (USD Million)
• TABLE 25. Other indications market size, 2025 - 2032 (USD Million)
• TABLE 26. In-house manufacturing market size, 2018 - 2024 (USD Million)
• TABLE 27. In-house manufacturing market size, 2025 - 2032 (USD Million)
• TABLE 28. Contract manufacturing market size, 2018 - 2024 (USD Million)
• TABLE 29. Contract manufacturing market size, 2025 - 2032 (USD Million)
• TABLE 30. Chemical based API market size, 2018 - 2024 (USD Million)
• TABLE 31. Chemical based API market size, 2025 - 2032 (USD Million)
• TABLE 32. Highly potent API (HPAPI) market size, 2018 - 2024 (USD Million)
• TABLE 33. Highly potent API (HPAPI) market size, 2025 - 2032 (USD Million)
• TABLE 34. North America methotrexate market size, by country, 2018 - 2024 (USD Million)
• TABLE 35. North America methotrexate market size, by country, 2025 - 2032 (USD Million)
• TABLE 36. North America methotrexate market size, by indication, 2018 - 2024 (USD Million)
• TABLE 37. North America methotrexate market size, by indication, 2025 - 2032 (USD Million)
• TABLE 38. North America methotrexate market size, by mode, 2018 - 2024 (USD Million)
• TABLE 39. North America methotrexate market size, by mode, 2025 - 2032 (USD Million)
• TABLE 40. North America methotrexate market size, by synthesis type, 2018 - 2024 (USD Million)
• TABLE 41. North America methotrexate market size, by synthesis type, 2025 - 2032 (USD Million)
• TABLE 42. U.S. methotrexate market size, by indication, 2018 - 2024 (USD Million)
• TABLE 43. U.S. methotrexate market size, by indication, 2025 - 2032 (USD Million)
• TABLE 44. U.S. methotrexate market size, by mode, 2018 - 2024 (USD Million)
• TABLE 45. U.S. methotrexate market size, by mode, 2025 - 2032 (USD Million)
• TABLE 46. U.S. methotrexate market size, by synthesis type, 2018 - 2024 (USD Million)
• TABLE 47. U.S. methotrexate market size, by synthesis type, 2025 - 2032 (USD Million)
• TABLE 48. Canada methotrexate market size, by indication, 2018 - 2024 (USD Million)
• TABLE 49. Canada methotrexate market size, by indication, 2025 - 2032 (USD Million)
• TABLE 50. Canada methotrexate market size, by mode, 2018 - 2024 (USD Million)
• TABLE 51. Canada methotrexate market size, by mode, 2025 - 2032 (USD Million)
• TABLE 52. Canada methotrexate market size, by synthesis type, 2018 - 2024 (USD Million)
• TABLE 53. Canada methotrexate market size, by synthesis type, 2025 - 2032 (USD Million)
• TABLE 54. Europe methotrexate market size, by country, 2018 - 2024 (USD Million)
• TABLE 55. Europe methotrexate market size, by country, 2025 - 2032 (USD Million)
• TABLE 56. Europe methotrexate market size, by indication, 2018 - 2024 (USD Million)
• TABLE 57. Europe methotrexate market size, by indication, 2025 - 2032 (USD Million)
• TABLE 58. Europe methotrexate market size, by mode, 2018 - 2024 (USD Million)
• TABLE 59. Europe methotrexate market size, by mode, 2025 - 2032 (USD Million)
• TABLE 60. Europe methotrexate market size, by synthesis type, 2018 - 2024 (USD Million)
• TABLE 61. Europe methotrexate market size, by synthesis type, 2025 - 2032 (USD Million)
• TABLE 62. Germany methotrexate market size, by indication, 2018 - 2024 (USD Million)
• TABLE 63. Germany methotrexate market size, by indication, 2025 - 2032 (USD Million)
• TABLE 64. Germany methotrexate market size, by mode, 2018 - 2024 (USD Million)
• TABLE 65. Germany methotrexate market size, by mode, 2025 - 2032 (USD Million)
• TABLE 66. Germany methotrexate market size, by synthesis type, 2018 - 2024 (USD Million)
• TABLE 67. Germany methotrexate market size, by synthesis type, 2025 - 2032 (USD Million)
• TABLE 68. UK methotrexate market size, by indication, 2018 - 2024 (USD Million)
• TABLE 69. UK methotrexate market size, by indication, 2025 - 2032 (USD Million)
• TABLE 70. UK methotrexate market size, by mode, 2018 - 2024 (USD Million)
• TABLE 71. UK methotrexate market size, by mode, 2025 - 2032 (USD Million)
• TABLE 72. UK methotrexate market size, by synthesis type, 2018 - 2024 (USD Million)
• TABLE 73. UK methotrexate market size, by synthesis type, 2025 - 2032 (USD Million)
• TABLE 74. France methotrexate market size, by indication, 2018 - 2024 (USD Million)
• TABLE 75. France methotrexate market size, by indication, 2025 - 2032 (USD Million)
• TABLE 76. France methotrexate market size, by mode, 2018 - 2024 (USD Million)
• TABLE 77. France methotrexate market size, by mode, 2025 - 2032 (USD Million)
• TABLE 78. France methotrexate market size, by synthesis type, 2018 - 2024 (USD Million)
• TABLE 79. France methotrexate market size, by synthesis type, 2025 - 2032 (USD Million)
• TABLE 80. Italy methotrexate market size, by indication, 2018 - 2024 (USD Million)
• TABLE 81. Italy methotrexate market size, by indication, 2025 - 2032 (USD Million)
• TABLE 82. Italy methotrexate market size, by mode, 2018 - 2024 (USD Million)
• TABLE 83. Italy methotrexate market size, by mode, 2025 - 2032 (USD Million)
• TABLE 84. Italy methotrexate market size, by synthesis type, 2018 - 2024 (USD Million)
• TABLE 85. Italy methotrexate market size, by synthesis type, 2025 - 2032 (USD Million)
• TABLE 86. Spain methotrexate market size, by indication, 2018 - 2024 (USD Million)
• TABLE 87. Spain methotrexate market size, by indication, 2025 - 2032 (USD Million)
• TABLE 88. Spain methotrexate market size, by mode, 2018 - 2024 (USD Million)
• TABLE 89. Spain methotrexate market size, by mode, 2025 - 2032 (USD Million)
• TABLE 90. Spain methotrexate market size, by synthesis type, 2018 - 2024 (USD Million)
• TABLE 91. Spain methotrexate market size, by synthesis type, 2025 - 2032 (USD Million)
• TABLE 92. Russia methotrexate market size, by indication, 2018 - 2024 (USD Million)
• TABLE 93. Russia methotrexate market size, by indication, 2025 - 2032 (USD Million)
• TABLE 94. Russia methotrexate market size, by mode, 2018 - 2024 (USD Million)
• TABLE 95. Russia methotrexate market size, by mode, 2025 - 2032 (USD Million)
• TABLE 96. Russia methotrexate market size, by synthesis type, 2018 - 2024 (USD Million)
• TABLE 97. Russia methotrexate market size, by synthesis type, 2025 - 2032 (USD Million)
• TABLE 98. Rest of Europe methotrexate market size, by indication, 2018 - 2024 (USD Million)
• TABLE 99. Rest of Europe methotrexate market size, by indication, 2025 - 2032 (USD Million)
• TABLE 100. Rest of Europe methotrexate market size, by mode, 2018 - 2024 (USD Million)
• TABLE 101. Rest of Europe methotrexate market size, by mode, 2025 - 2032 (USD Million)
• TABLE 102. Rest of Europe methotrexate market size, by synthesis type, 2018 - 2024 (USD Million)
• TABLE 103. Rest of Europe methotrexate market size, by synthesis type, 2025 - 2032 (USD Million)
• TABLE 104. Asia Pacific methotrexate market size, by country, 2018 - 2024 (USD Million)
• TABLE 105. Asia Pacific methotrexate market size, by country, 2025 - 2032 (USD Million)
• TABLE 106. Asia Pacific methotrexate market size, by indication, 2018 - 2024 (USD Million)
• TABLE 107. Asia Pacific methotrexate market size, by indication, 2025 - 2032 (USD Million)
• TABLE 108. Asia Pacific methotrexate market size, by mode, 2018 - 2024 (USD Million)
• TABLE 109. Asia Pacific methotrexate market size, by mode, 2025 - 2032 (USD Million)
• TABLE 110. Asia Pacific methotrexate market size, by synthesis type, 2018 - 2024 (USD Million)
• TABLE 111. Asia Pacific methotrexate market size, by synthesis type, 2025 - 2032 (USD Million)
• TABLE 112. China methotrexate market size, by indication, 2018 - 2024 (USD Million)
• TABLE 113. China methotrexate market size, by indication, 2025 - 2032 (USD Million)
• TABLE 114. China methotrexate market size, by mode, 2018 - 2024 (USD Million)
• TABLE 115. China methotrexate market size, by mode, 2025 - 2032 (USD Million)
• TABLE 116. China methotrexate market size, by synthesis type, 2018 - 2024 (USD Million)
• TABLE 117. China methotrexate market size, by synthesis type, 2025 - 2032 (USD Million)
• TABLE 118. Japan methotrexate market size, by indication, 2018 - 2024 (USD Million)
• TABLE 119. Japan methotrexate market size, by indication, 2025 - 2032 (USD Million)
• TABLE 120. Japan methotrexate market size, by mode, 2018 - 2024 (USD Million)
• TABLE 121. Japan methotrexate market size, by mode, 2025 - 2032 (USD Million)
• TABLE 122. Japan methotrexate market size, by synthesis type, 2018 - 2024 (USD Million)
• TABLE 123. Japan methotrexate market size, by synthesis type, 2025 - 2032 (USD Million)
• TABLE 124. India methotrexate market size, by indication, 2018 - 2024 (USD Million)
• TABLE 125. India methotrexate market size, by indication, 2025 - 2032 (USD Million)
• TABLE 126. India methotrexate market size, by mode, 2018 - 2024 (USD Million)
• TABLE 127. India methotrexate market size, by mode, 2025 - 2032 (USD Million)
• TABLE 128. India methotrexate market size, by synthesis type, 2018 - 2024 (USD Million)
• TABLE 129. India methotrexate market size, by synthesis type, 2025 - 2032 (USD Million)
• TABLE 130. South Korea methotrexate market size, by indication, 2018 - 2024 (USD Million)
• TABLE 131. South Korea methotrexate market size, by indication, 2025 - 2032 (USD Million)
• TABLE 132. South Korea methotrexate market size, by mode, 2018 - 2024 (USD Million)
• TABLE 133. South Korea methotrexate market size, by mode, 2025 - 2032 (USD Million)
• TABLE 134. South Korea methotrexate market size, by synthesis type, 2018 - 2024 (USD Million)
• TABLE 135. South Korea methotrexate market size, by synthesis type, 2025 - 2032 (USD Million)
• TABLE 136. Malaysia methotrexate market size, by indication, 2018 - 2024 (USD Million)
• TABLE 137. Malaysia methotrexate market size, by indication, 2025 - 2032 (USD Million)
• TABLE 138. Malaysia methotrexate market size, by mode, 2018 - 2024 (USD Million)
• TABLE 139. Malaysia methotrexate market size, by mode, 2025 - 2032 (USD Million)
• TABLE 140. Malaysia methotrexate market size, by synthesis type, 2018 - 2024 (USD Million)
• TABLE 141. Malaysia methotrexate market size, by synthesis type, 2025 - 2032 (USD Million)
• TABLE 142. Australia methotrexate market size, by indication, 2018 - 2024 (USD Million)
• TABLE 143. Australia methotrexate market size, by indication, 2025 - 2032 (USD Million)
• TABLE 144. Australia methotrexate market size, by mode, 2018 - 2024 (USD Million)
• TABLE 145. Australia methotrexate market size, by mode, 2025 - 2032 (USD Million)
• TABLE 146. Australia methotrexate market size, by synthesis type, 2018 - 2024 (USD Million)
• TABLE 147. Australia methotrexate market size, by synthesis type, 2025 - 2032 (USD Million)
• TABLE 148. Rest of Asia Pacific methotrexate market size, by indication, 2018 - 2024 (USD Million)
• TABLE 149. Rest of Asia Pacific methotrexate market size, by indication, 2025 - 2032 (USD Million)
• TABLE 150. Rest of Asia Pacific methotrexate market size, by mode, 2018 - 2024 (USD Million)
• TABLE 151. Rest of Asia Pacific methotrexate market size, by mode, 2025 - 2032 (USD Million)
• TABLE 152. Rest of Asia Pacific methotrexate market size, by synthesis type, 2018 - 2024 (USD Million)
• TABLE 153. Rest of Asia Pacific methotrexate market size, by synthesis type, 2025 - 2032 (USD Million)
• TABLE 154. Latin America methotrexate market size, by country, 2018 - 2024 (USD Million)
• TABLE 155. Latin America methotrexate market size, by country, 2025 - 2032 (USD Million)
• TABLE 156. Latin America methotrexate market size, by indication, 2018 - 2024 (USD Million)
• TABLE 157. Latin America methotrexate market size, by indication, 2025 - 2032 (USD Million)
• TABLE 158. Latin America methotrexate market size, by mode, 2018 - 2024 (USD Million)
• TABLE 159. Latin America methotrexate market size, by mode, 2025 - 2032 (USD Million)
• TABLE 160. Latin America methotrexate market size, by synthesis type, 2018 - 2024 (USD Million)
• TABLE 161. Latin America methotrexate market size, by synthesis type, 2025 - 2032 (USD Million)
• TABLE 162. Brazil methotrexate market size, by indication, 2018 - 2024 (USD Million)
• TABLE 163. Brazil methotrexate market size, by indication, 2025 - 2032 (USD Million)
• TABLE 164. Brazil methotrexate market size, by mode, 2018 - 2024 (USD Million)
• TABLE 165. Brazil methotrexate market size, by mode, 2025 - 2032 (USD Million)
• TABLE 166. Brazil methotrexate market size, by synthesis type, 2018 - 2024 (USD Million)
• TABLE 167. Brazil methotrexate market size, by synthesis type, 2025 - 2032 (USD Million)
• TABLE 168. Mexico methotrexate market size, by indication, 2018 - 2024 (USD Million)
• TABLE 169. Mexico methotrexate market size, by indication, 2025 - 2032 (USD Million)
• TABLE 170. Mexico methotrexate market size, by mode, 2018 - 2024 (USD Million)
• TABLE 171. Mexico methotrexate market size, by mode, 2025 - 2032 (USD Million)
• TABLE 172. Mexico methotrexate market size, by synthesis type, 2018 - 2024 (USD Million)
• TABLE 173. Mexico methotrexate market size, by synthesis type, 2025 - 2032 (USD Million)
• TABLE 174. Rest of Latin America methotrexate market size, by indication, 2018 - 2024 (USD Million)
• TABLE 175. Rest of Latin America methotrexate market size, by indication, 2025 - 2032 (USD Million)
• TABLE 176. Rest of Latin America methotrexate market size, by mode, 2018 - 2024 (USD Million)
• TABLE 177. Rest of Latin America methotrexate market size, by mode, 2025 - 2032 (USD Million)
• TABLE 178. Rest of Latin America methotrexate market size, by synthesis type, 2018 - 2024 (USD Million)
• TABLE 179. Rest of Latin America methotrexate market size, by synthesis type, 2025 - 2032 (USD Million)
• TABLE 180. Middle East & Africa methotrexate market size, by country, 2018 - 2024 (USD Million)
• TABLE 181. Middle East & Africa methotrexate market size, by country, 2025 - 2032 (USD Million)
• TABLE 182. Middle East & Africa methotrexate market size, by indication, 2018 - 2024 (USD Million)
• TABLE 183. Middle East & Africa methotrexate market size, by indication, 2025 - 2032 (USD Million)
• TABLE 184. Middle East & Africa methotrexate market size, by mode, 2018 - 2024 (USD Million)
• TABLE 185. Middle East & Africa methotrexate market size, by mode, 2025 - 2032 (USD Million)
• TABLE 186. Middle East & Africa methotrexate market size, by synthesis type, 2018 - 2024 (USD Million)
• TABLE 187. Middle East & Africa methotrexate market size, by synthesis type, 2025 - 2032 (USD Million)
• TABLE 188. South Africa methotrexate market size, by indication, 2018 - 2024 (USD Million)
• TABLE 189. South Africa methotrexate market size, by indication, 2025 - 2032 (USD Million)
• TABLE 190. South Africa methotrexate market size, by mode, 2018 - 2024 (USD Million)
• TABLE 191. South Africa methotrexate market size, by mode, 2025 - 2032 (USD Million)
• TABLE 192. South Africa methotrexate market size, by synthesis type, 2018 - 2024 (USD Million)
• TABLE 193. South Africa methotrexate market size, by synthesis type, 2025 - 2032 (USD Million)
• TABLE 194. Saudi Arabia methotrexate market size, by indication, 2018 - 2024 (USD Million)
• TABLE 195. Saudi Arabia methotrexate market size, by indication, 2025 - 2032 (USD Million)
• TABLE 196. Saudi Arabia methotrexate market size, by mode, 2018 - 2024 (USD Million)
• TABLE 197. Saudi Arabia methotrexate market size, by mode, 2025 - 2032 (USD Million)
• TABLE 198. Saudi Arabia methotrexate market size, by synthesis type, 2018 - 2024 (USD Million)
• TABLE 199. Saudi Arabia methotrexate market size, by synthesis type, 2025 - 2032 (USD Million)
• TABLE 200. UAE methotrexate market size, by indication, 2018 - 2024 (USD Million)
• TABLE 201. UAE methotrexate market size, by indication, 2025 - 2032 (USD Million)
• TABLE 202. UAE methotrexate market size, by mode, 2018 - 2024 (USD Million)
• TABLE 203. UAE methotrexate market size, by mode, 2025 - 2032 (USD Million)
• TABLE 204. UAE methotrexate market size, by synthesis type, 2018 - 2024 (USD Million)
• TABLE 205. UAE methotrexate market size, by synthesis type, 2025 - 2032 (USD Million)
• TABLE 206. Rest of MEA methotrexate market size, by indication, 2018 - 2024 (USD Million)
• TABLE 207. Rest of MEA methotrexate market size, by indication, 2025 - 2032 (USD Million)
• TABLE 208. Rest of MEA methotrexate market size, by mode, 2018 - 2024 (USD Million)
• TABLE 209. Rest of MEA methotrexate market size, by mode, 2025 - 2032 (USD Million)
• TABLE 210. Rest of MEA methotrexate market size, by synthesis type, 2018 - 2024 (USD Million)
• TABLE 211. Rest of MEA methotrexate market size, by synthesis type, 2025 - 2032 (USD Million)

Charts & Figures

• FIG. 1 Research design
• FIG. 2 Data collection techniques
• FIG. 3 Primary research process
• FIG. 4 Market sizing approach
• FIG. 5 Forecasting model
• FIG. 6 Global industry snapshot
• FIG. 7 Industry ecosystem analysis
• FIG. 8 Growth potential analysis, by indication
• FIG. 9 Growth potential analysis, by mode
• FIG. 10 Growth potential analysis, by synthesis type
• FIG. 11 Porter's analysis
• FIG. 12 PESTEL analysis
• FIG. 13 Competitive analysis of major market players, 2022
• FIG. 14 Competitive positioning matrix, 2022
• FIG. 15 Strategic outlook matrix, 2022
• FIG. 16 Global company share analysis, 2022
• FIG. 17 North America company share analysis, 2022
• FIG. 18 Europe company share analysis, 2022
• FIG. 19 Asia Pacific company share analysis, 2022

The global methotrexate market is poised to record over 5% CAGR through 2032, propelled by the booming pharmaceutical sector. As healthcare priorities evolve, the demand for effective treatment options grows, highlighting the broadening spectrum of product's therapeutic applications.

The escalating incidence of chronic diseases is another main growth driver. As per a report by WHO in 2023, noncommunicable diseases (NCDs) claim the lives of 41 million individuals annually, representing 74% of global fatalities. Notably, 17 million people succumb to NCDs before the age of 70 years, with a substantial 86% of these premature deaths occurring in low- and middle-income countries. Methotrexate, a well-established disease-modifying antirheumatic drug (DMARD), has witnessed increased adoption due to its efficacy in managing autoimmune disorders such as rheumatoid arthritis and psoriasis. Furthermore, its role in cancer treatment, particularly in leukaemia and breast cancer, contributes significantly to the market growth.

The overall methotrexate market is classified based on indication, mode, synthesis type, and region.

The cancer segment is poised to witness significant gains during 2023-2032 driven by methotrexate's utility in chemotherapy protocols for leukaemia, breast cancer, and certain types of lymphomas. The continuous exploration of Methotrexate's potential in diverse cancer treatments underscores its importance as a cornerstone therapeutic agent in the oncology field.

The contract manufacturing segment is anticipated to witness robust growth during the forecast period. The pharmaceutical companies increasingly leverage contract manufacturing organizations (CMOs) to streamline production processes, enhance efficiency, and ensure compliance with regulatory standards. Collaborations with CMOs facilitate the seamless production and distribution of methotrexate, driving innovation and ensuring broader accessibility for patients globally.

Asia Pacific methotrexate market is expected to register swift growth through 2032 driven by the region's burgeoning population and evolving healthcare infrastructure. There is an increased prevalence of chronic diseases, driving the demand for effective treatment options. Countries like China and India, with their expanding pharmaceutical sectors, play a crucial role in the production and consumption of methotrexate, thereby shaping the regional market dynamics.

Table of Contents

Chapter 1 Methodology & Scope

• 1.1 Market scope & definition
• 1.2 Base estimates & workings
• 1.3 Forecast calculations
• 1.4 Data Sources
  • 1.4.1 Primary
  • 1.4.2 Secondary
    • 1.4.2.1 Paid sources
    • 1.4.2.2 Unpaid sources

Chapter 2 Executive Summary

• 2.1 Global methotrexate market 360 degree synopsis, 2018 - 2032
• 2.2 Regional trends
• 2.3 Indication trends
• 2.4 Mode trends
• 2.5 Synthesis type trends

Chapter 3 Methotrexate Industry Insights

• 3.1 COVID- 19 impact analysis
• 3.2 Industry ecosystem analysis
• 3.3 Technology landscape
• 3.4 Regulatory landscape
• 3.5 Industry impact forces
  • 3.5.1 Growth drivers
    • 3.5.1.1 Rising prevalence of chronic diseases
    • 3.5.1.2 Growing number of drug approvals by regulatory bodies
    • 3.5.1.3 Ongoing research and development using methotrexate drugs
    • 3.5.1.4 Rising technological advancements and demand for personalized medicine
  • 3.5.2 Industry pitfalls & challenges
    • 3.5.2.1 Adverse effects and safety concerns
    • 3.5.2.2 Limited reimbursement and coverage policies
• 3.6 Growth potential analysis
  • 3.6.1 By indication
  • 3.6.2 By mode
  • 3.6.3 By synthesis type
• 3.7 Porter's analysis
• 3.8 PESTEL analysis

Chapter 4 Competitive Landscape, 2022

• 4.1 Introduction
  • 4.1.1 Novartis AG (Sandoz)
  • 4.1.2 Merck & Co., Inc
  • 4.1.3 Sun Pharmaceutical Industries Ltd
• 4.2 Competitive positioning matrix, 2022
• 4.3 Market share/ rank analysis
  • 4.3.1 Global
  • 4.3.2 North America
  • 4.3.3 Europe
  • 4.3.4 Asia Pacific
• 4.4 Production capacity
• 4.5 List of top 20 end consumers with contact details/email id

Chapter 5 Methotrexate Market Estimates and Forecast, By Indication (Revenue)

• 5.1 Key trends, by indication
• 5.2 Psoriasis
• 5.3 Rheumatoid arthritis
• 5.4 Cancer
• 5.5 Others

Chapter 6 Methotrexate Market Estimates and Forecast, By Mode (Revenue)

• 6.1 Key trends, by mode
• 6.2 In-house
• 6.3 Contract manufacturing

Chapter 7 Methotrexate Market Estimates and Forecast, By Synthesis Type (Revenue)

• 7.1 Key trends, by synthesis type
• 7.2 Chemical based API
• 7.3 Highly potent API (HPAPI)

Chapter 8 Methotrexate Market Estimates and Forecast, By Region (Revenue & Volume)

• 8.1 Key trends, by region
• 8.2 North America
  • 8.2.1 U.S.
  • 8.2.2 Canada
• 8.3 Europe
  • 8.3.1 Germany
  • 8.3.2 UK
  • 8.3.3 France
  • 8.3.4 Italy
  • 8.3.5 Spain
  • 8.3.6 Russia
• 8.4 Asia Pacific
  • 8.4.1 China
  • 8.4.2 Japan
  • 8.4.3 India
  • 8.4.4 Australia
  • 8.4.5 South Korea
  • 8.4.6 Malaysia
• 8.5 Latin America
  • 8.5.1 Brazil
  • 8.5.2 Mexico
• 8.6 Middle East & Africa
  • 8.6.1 Saudi Arabia
  • 8.6.2 South Africa
  • 8.6.3 UAE

Chapter 9 Company Profiles

• 9.1 Teva Pharmaceutical Industries Ltd
• 9.2 Sun Pharmaceutical Industries Ltd
• 9.3 Aurobindo Pharma Ltd
• 9.4 Lonza Group AG
• 9.5 Merck & Co., Inc
• 9.6 Fermion (Orion Corporation)
• 9.7 Avra Laboratories Pvt Ltd
• 9.8 Rochem International Inc
• 9.9 LGM Pharm
• 9.10 Sandoz AG (Novartis AG)